Post-normal science in the multilateral trading system: social science expertise and the EC–Biotech Panel

Mary E. Footer

World Trade Review, 2007, vol. 6, issue 2, 281-297

Abstract: The recent EC–Biotech case highlights the emerging regulatory divide between WTO Members and reveals a deepening crisis over issues of science and governance in the world trading system. This article focuses on the potential role that social science expertise might play as an analytical tool in understanding trade disputes involving scientific expertise relating to matters of risk assessment and polycentric decision-making. Particular consideration is given to the paradigm of ‘post-normal’ science, which pertains in situations where competent national authorities have to frame and implement policies before all the (scientific) facts are known. As the amicus curiae brief by a group of five social scientists before the EC–Biotech Panel demonstrates, where there is a high degree of scientific uncertainty, as in the case of GM products, post-normal science can offer a valuable means of framing the dispute in a broader societal context than the sound science approach, which is used to assess health, safety, and environmental risks under the SPS Agreement.

Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:wotrrv:v:6:y:2007:i:02:p:281-297_00

Access Statistics for this article

More articles in World Trade Review from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().